Trials / Conditions / Liver Cell Carcinoma

Liver Cell Carcinoma

10 registered clinical trials studyying Liver Cell Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors NCT07224568	Seattle Children's Hospital	Phase 1
Recruiting	Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-speci NCT07148050	Seattle Children's Hospital	Phase 1
Not Yet Recruiting	Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC NCT05195294	Lion TCR Pte. Ltd.	Phase 2
Recruiting	Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma NCT05366829	Rutgers, The State University of New Jersey	Phase 2
Active Not Recruiting	Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid NCT05103631	Baylor College of Medicine	Phase 1
Completed	A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never NCT04567615	Bristol-Myers Squibb	Phase 2
Withdrawn	HepATocellular Cancer Hcv Therapy Study NCT04546802	Bayside Health	Phase 3
Terminated	TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma NCT02704130	Wake Forest University Health Sciences	N/A
Terminated	A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma NCT02460991	Boston Scientific Corporation	Phase 3
Terminated	Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular C NCT00669136	Lisa H. Butterfield, Ph.D.	Phase 1